Search Results

The intended use of the Unotech Accutest hCG-Combo is for the qualitative determination of human chorionic gonadotropin (hCG) in human urine or serum for the early detection of pregnancy.

The intended use of the Unotech Accustrip hCG-Combo is for the qualitative determination of human chorionic gonadotropin (hCG) in human urine or serum for the early detection of pregnancy.

Not Found

The Unotech AccuTest™ hCG-Combo and AccuStrip™ hCG-Combo are intended for the qualitative determination of human chorionic gonadotropin (hCG) in human urine or serum for the early detection of pregnancy. The study demonstrates the substantial equivalence of the Unotech devices to the Quidel QuickVue hCG Combo Test.

Acceptance Criteria and Reported Device Performance

Study Details

2. Sample Sizes and Data Provenance

• Comparison Study:
  • Test Set Size: 181 specimens (94 urine specimens, 87 serum specimens).
  • Data Provenance: The document does not explicitly state the country of origin, but it mentions "patients seeking confirmation of pregnancy," suggesting clinical samples. The study appears to be retrospective, using collected specimens.
• Sensitivity Study:
  • Test Set Size: 60 urine samples and 60 serum samples (10 samples for each of the 6 hCG concentrations tested for both urine and serum).
  • Data Provenance: Negative pooled urine and serum specimens were "spiked with hCG," indicating a controlled laboratory setting.

3. Number of Experts and Qualifications for Ground Truth

• Not applicable. The ground truth for the comparison study was established by the predicate device (Quidel QuickVue hCG Combo Test). For the sensitivity study, the ground truth was based on the known spiked concentrations of hCG.

4. Adjudication Method

• Not applicable. Ground truth was established by the predicate device or known concentrations, not by expert adjudication.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

• No, a multi-reader multi-case comparative effectiveness study was not done. This study is for an in-vitro diagnostic device, not an AI or imaging device requiring human reader interpretation enhancement.

6. Standalone (Algorithm Only) Performance

• Yes, a standalone performance study was done. The performance of the Unotech AccuTest™ hCG-Combo and AccuStrip™ hCG-Combo was evaluated directly against a predicate device and against known spiked concentrations without human interpretation as part of the primary outcome.

7. Type of Ground Truth Used

• Comparison Study: Reference standard (predicate device - Quidel QuickVue hCG Combo Test) results.
• Sensitivity Study: Known concentrations of hCG in spiked samples.

8. Sample Size for the Training Set

• Not applicable. This is an in-vitro diagnostic device study, not an AI/machine learning study that typically involves training sets.

9. How the Ground Truth for the Training Set was Established

• Not applicable, as there was no training set in the context of an AI/machine learning model.

Ask a specific question about this device

The intended use of the Unotech AccuStrip hCG-Urine is for the qualitative determination of human chorionic gonadotropin (hCG) in human urine for the early detection of pregnancy. We intend to market this product to physicians' office laboratories and clinical laboratories in the U.S.A. as well as in the foreign countries.

Not Found

Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:

Acceptance Criteria and Device Performance for AccuStrip™ hCG-Urine

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria for the AccuStrip™ hCG-Urine device seem to be implicitly defined by its agreement with a predicate device (Unotech AccuTest™ hCG-Urine) and its ability to detect hCG at specific concentration ranges.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: 208 urine specimens were tested for clinical comparison with the predicate device. For sensitivity testing, 10 samples were used at each of 9 different hCG concentrations (0, 25, 50, 10², 10³, 10⁴, 10⁵, 5x10⁵, and 10⁶ mIU/mL), totaling 90 samples.
• Data Provenance: The clinical study was conducted in "three physicians' office laboratories." The origin of the urine specimens is described as "Clinical subjects included female patients seeking confirmation of pregnancy, those who were confirmed pregnant, and 19 post-menopausal women," implying the data is from relevant patient populations, likely in the US where the physicians' offices are located. The study is prospective in the sense that the new device was tested on collected samples alongside the predicate. Clinical subjects are mentioned, suggesting a patient-derived dataset.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The document does not explicitly state the number of experts or their qualifications for establishing the ground truth.

• For the clinical agreement study, the "ground truth" for the AccuStrip™ hCG-Urine was established by its agreement with the Unotech AccuTest™ hCG-Urine, which is the predicate device. It's assumed the predicate device itself provides an accepted standard.
• For the sensitivity study, the "ground truth" was based on known, spiked concentrations of hCG in urine samples.

4. Adjudication Method for the Test Set

No explicit adjudication method is described. For the clinical comparison, the primary method was direct agreement with the predicate device's results. For the sensitivity testing, the results were compared against known hCG concentrations.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No, an MRMC comparative effectiveness study was not done. This study focuses on the standalone performance of the AccuStrip™ hCG-Urine compared to another device and against known concentrations. It does not evaluate human readers' improvement with or without AI assistance, as this is a diagnostic test kit, not an AI-assisted diagnostic tool.

6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

Yes, a standalone performance evaluation was conducted. The AccuStrip™ hCG-Urine is a diagnostic strip test, and its results are read directly, likely by a healthcare professional or lab technician. The studies described – clinical agreement and sensitivity testing – assess the performance of the device itself (the "algorithm" in a broad sense for a chemical test), independent of interpretive assistance for its users beyond the inherent design of the test.

7. The Type of Ground Truth Used

• For the clinical comparison, the ground truth was comparison to a predicate device (Unotech AccuTest™ hCG-Urine).
• For the sensitivity and specificity testing, the ground truth was known, manufactured concentrations of hCG in urine samples.

8. The Sample Size for the Training Set

The document does not mention a separate training set. This is typical for traditional diagnostic test kits that are developed through chemical and biological experimentation and validation, rather than machine learning algorithms which require training data. The "studies" described are validation studies.

9. How the Ground Truth for the Training Set Was Established

As no training set is described, this question is not applicable.

Ask a specific question about this device

The intended use of the Unotech AccuTest hCG-Urine is for the qualitative determination of human chorionic gonadotropin (hCG) in human urine for the early detection of pregnancy. We intend to market this product to physicians' offices laboratories and clinical laboratories in the U.S.A. as well as in the foreign countries.

Not Found

The Unotech Diagnostics Inc. AccuTest™ hCG-Urine is a Human Chorionic Gonadotropin Test System intended for the qualitative determination of human chorionic gonadotropin (hCG) in human urine for the early detection of pregnancy. The device aims to achieve 100% agreement with a legally marketed predicate device (Abbott TestPack Plus™ hCG-COMBO) in clinical settings and demonstrate its ability to detect hCG across a specific concentration range.

Here's an analysis of the acceptance criteria and the study that proves the device meets these criteria:

1. Acceptance Criteria and Reported Device Performance

The summary table explicitly states the 100% agreement for the clinical study. For the analytical sensitivity, the text and the accompanying table confirm detection across the specified range, including 25 mIU/mL and 1,000,000 mIU/mL, as well as accurate negative results at 0 mIU/mL.

2. Sample size used for the test set and the data provenance

• Sample Size for Clinical Study: 197 urine specimens.

• Data Provenance: The study was a multicenter clinical study conducted in three physicians' offices laboratories. The clinical subjects included female patients seeking confirmation of pregnancy, those who were confirmed pregnant, and 8 post-menopausal women. This indicates the data is prospective and originated from clinical settings in the USA.

• Sample Size for Analytical Sensitivity Study: For each hCG concentration level (0, 25, 50, 10^2^, 10^3^, 10^4^, 10^5^, 5x10^5^, 10^6^ mIU/mL), 10 samples were tested. This totals 90 samples for the analytical sensitivity testing.

• Data Provenance for Analytical Sensitivity Study: The provenance of these specifically spiked samples is not explicitly stated but is implicitly a controlled laboratory setting, performed by Unotech Diagnostics Inc.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

The provided text does not specify the number of experts or their qualifications used to establish the ground truth for the test set.

However, the "ground truth" for the clinical agreement study was established by the Abbott TestPack Plus™ hCG-COMBO, which is a legally marketed predicate device. This implies that the predicate device's results were considered the reference standard for comparison. For the analytical sensitivity study, the ground truth was established by the known concentrations of hCG in the spiked urine samples.

4. Adjudication method for the test set

The provided text does not mention any adjudication method (e.g., 2+1, 3+1) for the test set. The comparison for the clinical study was directly against the results of the predicate device, the Abbott TestPack Plus™ hCG-COMBO. For the analytical study, it was a direct comparison to known hCG concentrations.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and if so, what was the effect size of how much human readers improve with AI vs without AI assistance

No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. This device is a rapid diagnostic test (a chemical assay), not an AI-assisted diagnostic, so the concept of human readers improving with AI assistance is not applicable.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

The device itself is a standalone, qualitative diagnostic test (AccuTest™ hCG-Urine). The performance described in the document is the standalone performance of the device (without human-in-the-loop interaction beyond performing the test according to instructions). It's a chemical test, not an algorithm.

7. The type of ground truth used

• For the Clinical Study: The ground truth was established by the results of a legally marketed predicate device, the Abbott TestPack Plus™ hCG-COMBO. Additionally, the clinical subjects included "female patients seeking confirmation of pregnancy" and "those who were confirmed pregnant," implying that the clinical status (confirmed pregnancy or not) also served as a form of ground truth for assessing the test's agreement with the predicate.
• For the Analytical Sensitivity and Specificity Study: The ground truth was based on known, pre-defined concentrations of hCG in urine samples (0, 25, 50, etc., mIU/mL).

8. The sample size for the training set

This device is not an AI/ML algorithm that requires a "training set." It is a chemical diagnostic test. Therefore, the concept of a training set is not applicable.

9. How the ground truth for the training set was established

As explained in point 8, the concept of a training set is not applicable to this type of chemical diagnostic device.

Ask a specific question about this device